Making sense in antisense: Therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Eken, Suzanne M ^a   Jin, Hong ^a   Chernogubova, Ekaterina ^a   Maegdefessel, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; INSULIN; UNTRANSLATED RNA;

ANIMAL; DIABETIC ANGIOPATHY; GENETICS; HUMAN; HYPERGLYCEMIA; METABOLISM; MICROARRAY ANALYSIS; PHYSIOLOGY; REVIEW;

ANIMALS; DIABETIC ANGIOPATHIES; HUMANS; HYPERGLYCEMIA; INSULIN; MICROARRAY ANALYSIS; RNA, ANTISENSE; RNA, UNTRANSLATED;

EID: 84893740620     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/834727     Document Type: Article

References (104)

1. Pasterkamp G., Methods of accelerated atherosclerosis in diabetic patients. Heart 2013 99 10 743 749
2. Cade W. T., Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Physical Therapy 2008 88 11 1322 1335 2-s2.0-55849133043 10.2522/ptj.20080008
3. Bender S. B., McGraw A. P., Jaffe I. Z., Sowers J. R., Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Diabetes 2013 62 2 313 319
4. Gibbons G. W., Shaw P. M., Diabetic vascular disease: characteristics of vascular disease unique to the diabetic patient. Seminars in Vascular Surgery 2012 25 2 89 92
5. Kim J.-A., Montagnani M., Kwang K. K., Quon M. J., Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006 113 15 1888 1904 2-s2.0-33646178955 10.1161/CIRCULATIONAHA.105.563213 (Pubitemid 43739401)
6. Dantas A. P., Fortes Z. B., de Carvalho M. H., Vascular disease in diabetic women: why do they miss the female protection? Experimental Diabetes Research 2012 2012 10 10.1155/2012/570598 570598
7. Li Q., Park K., Li C., Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C- β isoform in the endothelium. Circulation Research 2013 113 4 418 427
8. Förstermann U., Sessa W. C., Nitric oxide synthases: regulation and function. European Heart Journal 2012 33 7 829 837 2-s2.0-84859487532 10.1093/eurheartj/ehr304
9. Paneni F., Beckman J. A., Creager M. A., Cosentino F., Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy-part I. European Heart Journal 2013 34 31 2436 2443
10. Brunner H., Cockcroft J. R., Deanfield J., Donald A., Ferrannini E., Halcox J., Kiowski W., Lüscher T. F., Mancia G., Natali A., Oliver J. J., Pessina A. C., Rizzoni D., Rossi G. P., Salvetti A., Spieker L. E., Taddei S., Webb D. J., Endothelial function and dysfunction-part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Journal of Hypertension 2005 23 2 233 246 2-s2.0-20044373069 10.1097/00004872-200502000-00001 (Pubitemid 40279622)
11. Mooradian A. D., Dyslipidemia in type 2 diabetes mellitus. Nature Clinical Practice. Endocrinology & Metabolism 2009 5 3 150 159
12. Hermans M. P., Ahn S. A., Rousseau M. F., The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids in Health and Disease 2012 11, article 132
13. Stancu C. S., Toma L., Sima A. V., Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis. Cell and Tissue Research 2012 349 2 433 446
14. Hamilton S. J., Chew G. T., Davis T. M. E., Watts G. F., Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated type 2 diabetic patients. Clinical Science 2010 118 10 607 615 2-s2.0-77954078831 10.1042/CS20090568
15. Ceriello A., Assaloni R., da Ros R., Maier A., Piconi L., Quagliaro L., Esposito K., Giugliano D., Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005 111 19 2518 2524 2-s2.0-18844442889 10.1161/01.CIR.0000165070.46111.9F (Pubitemid 40696141)
16. Chan D. C., Wong A. T. Y., Yamashita S., Watts G. F., Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment. Atherosclerosis 2012 221 2 484 489 2-s2.0-84858697729 10.1016/j.atherosclerosis.2012.01.029
17. Cohen R. A., Tong X., Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. Journal of Cardiovascular Pharmacology 2010 55 4 308 316 2-s2.0-77951736264 10.1097/FJC.0b013e3181d89670
18. Schaffer S. W., Jong C. J., Mozaffari M., Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited. Vascular Pharmacology 2012 57 5-6 139 149 2-s2.0-84859555713 10.1016/j.vph.2012.03.005
19. Goldin A., Beckman J. A., Schmidt A. M., Creager M. A., Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006 114 6 597 605 2-s2.0-33746920337 10.1161/CIRCULATIONAHA.106. 621854 (Pubitemid 44199649)
20. Glass C. K., Witztum J. L., Atherosclerosis: the road ahead. Cell 2001 104 4 503 516 2-s2.0-0035936802 10.1016/S0092-8674(01)00238-0 (Pubitemid 32201946)
21. Park Y., Wu J., Zhang H., Wang Y., Zhang C., Vascular dysfunction in type 2 diabetes: emerging targets for therapy. Expert Review of Cardiovascular Therapy 2009 7 3 209 213 2-s2.0-66149163356 10.1586/14779072.7.3.209
22. Chandrasekar B., Boylston W. H., Venkatachalam K., Webster N. J. G., Prabhu S. D., Valente A. J., Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF- B/PTEN suppression. The Journal of Biological Chemistry 2008 283 36 24889 24898 2-s2.0-54049138456 10.1074/jbc.M804236200
23. Ouchi N., Parker J. L., Lugus J. J., Walsh K., Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011 11 2 85 97 2-s2.0-79151484704 10.1038/nri2921
24. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J.-I., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 1 79 83 2-s2.0-0033515761 10.1006/bbrc.1999.0255 (Pubitemid 29299050)
25. Koenig W., Khuseyinova N., Baumert J., Meisinger C., Löwel H., Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. Journal of the American College of Cardiology 2006 48 7 1369 1377 2-s2.0-33748933358 10.1016/j.jacc.2006.06.053 (Pubitemid 44436825)
26. Duncan B. B., Schmidt M. I., Pankow J. S., Bang H., Couper D., Ballantyne C. M., Hoogeveen R. C., Heiss G., Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004 53 9 2473 2478 2-s2.0-4344665855 10.2337/diabetes.53.9.2473 (Pubitemid 39145606)
27. van de Voorde J., Pauwels B., Boydens C., Decaluwé K., Adipocytokines in relation to cardiovascular disease. Metabolism 2013 62 11 1513 1521 10.1016/j.metabol.2013.06.004
28. Manuel-Apolinar L., López-Romero R., Zarate A., Damasio L., Ruiz M., Castillo-Hernández C., Guevara G., Mera-Jiménez E., Leptin mediated ObRb receptor increases expression of adhesion intercellular molecules and cyclooxygenase 2 on murine aorta tissue inducing endothelial dysfunction. International Journal of Clinical and Experimental Medicine 2013 6 3 192 196
29. Elkalioubie A., Zawadzki C., Roma-Lavisse C., Free leptin, carotid plaque phenotype and relevance to related symptomatology: insights from the OPAL-Lille carotid endarterectomy study. International Journal of Cardiology 2013 168 5 4879 4881 10.1016/j.ijcard.2013.07.048
30. Jamaluddin M. S., Weakley S. M., Yao Q., Chen C., Resistin: functional roles and therapeutic considerations for cardiovascular disease. British Journal of Pharmacology 2012 165 3 622 632 2-s2.0-84855646847 10.1111/j.1476-5381.2011. 01369.x
31. Northcott J. M., Yeganeh A., Taylor C. G., Zahradka P., Wigle J. T., Adipokines and the cardiovascular system: mechanisms mediating health and disease. Canadian Journal of Physiology and Pharmacology 2012 90 8 1029 1059
32. Falcao-Pires I., Castro-Chaves P., Miranda-Silva D., Lourenço A. P., Leite-Moreira A. F., Physiological, pathological and potential therapeutic roles of adipokines. Drug Discovery Today 2012 17 15-16 880 889 10.1016/j.drudis.2012.04.007
33. Mattick J. S., Makunin I. V., Non-coding RNA. Human Molecular Genetics 2006 15 supplement 1 R17 R29 2-s2.0-33646782348 10.1093/hmg/ddl046
34. Wightman B., Burglin T. R., Gatto J., Arasu P., Ruvkun G., Negative regulatory sequences in the lin-14 3′-untranslated region are necessary to generate a temporal switch during Caenorhabditis elegans development. Genes and Development 1991 5 10 1813 1824 2-s2.0-0025942586 (Pubitemid 21905876)
35. Lee R. C., Feinbaum R. L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 75 5 843 854 2-s2.0-0027751663 10.1016/0092-8674(93)90529-Y (Pubitemid 24014542)
36. Friedman R. C., Farh K. K.-H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009 19 1 92 105 2-s2.0-60149095444 10.1101/gr.082701.108
37. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
38. Rayner K. J., Esau C. C., Hussain F. N., McDaniel A. L., Marshall S. M., Van Gils J. M., Ray T. D., Sheedy F. J., Goedeke L., Liu X., Khatsenko O. G., Kaimal V., Lees C. J., Fernandez-Hernando C., Fisher E. A., Temel R. E., Moore K. J., Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011 478 7369 404 407 2-s2.0-80054971110 10.1038/nature10486
39. Janssen H. L., Reesink H. W., Lawitz E. J., Treatment of HCV infection by targeting microRNA. The New England Journal of Medicine 2013 368 18 1685 1694 10.1056/NEJMoa1209026
40. Mause S. F., Weber C., Microparticles: protagonists of a novel communication network for intercellular information exchange. Circulation Research 2010 107 9 1047 1057 2-s2.0-78349285166 10.1161/CIRCRESAHA.110.226456
41. Rinn J. L., Chang H. Y., Genome regulation by long noncoding RNAs. The Annual Review of Biochemistry 2012 81 145 166
42. Djebali S., Davis C. A., Merkel A., Landscape of transcription in human cells. Nature 2012 489 7414 101 108 10.1038/nature11233
43. Leung A., Trac C., Jin W., Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circulation Research 2013 113 3 266 278 10.1161/CIRCRESAHA.112.300849
44. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., Shah A., Willeit J., Mayr M., Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and other MicroRNAs in type 2 diabetes. Circulation Research 2010 107 6 810 817 2-s2.0-77957259803 10.1161/CIRCRESAHA.110.226357
45. Rong Y., Bao W., Shan Z., Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus. PLoS ONE 2013 8 9 10.1371/journal.pone.0073272 e73272
46. Gallagher I. J., Scheele C., Keller P., Nielsen A. R., Remenyi J., Fischer C. P., Roder K., Babraj J., Wahlestedt C., Hutvagner G., Pedersen B. K., Timmons J. A., Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Medicine 2010 2 2, article 9 2-s2.0-77958195688 10.1186/gm130
47. Granjon A., Gustin M.-P., Rieusset J., Lefai E., Meugnier E., Güller I., Cerutti C., Paultre C., Disse E., Rabasa-Lhoret R., Laville M., Vidal H., Rome S., The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway. Diabetes 2009 58 11 2555 2564 2-s2.0-71049132736 10.2337/db09-0165
48. Dumortier O., Hinault C., van Obberghen E., MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metabolism 2013 18 3 312 324
49. Mayr C., Hemann M. T., Bartel D. P., Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007 315 5818 1576 1579 2-s2.0-33947431322 10.1126/science.1137999 (Pubitemid 46449474)
50. Ambros V., Horvitz H. R., Heterochronic mutants of the nematode Caenorhabditis elegans. Science 1984 226 4673 409 416 2-s2.0-0021771445
51. Frost R. J. A., Olson E. N., Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proceedings of the National Academy of Sciences of the United States of America 2011 108 52 21075 21080 2-s2.0-84855518254 10.1073/pnas.1118922109
52. Zhu H., Ng S.-C., Segr A. V., Shinoda G., Shah S. P., Einhorn W. S., Takeuchi A., Engreitz J. M., Hagan J. P., Kharas M. G., Urbach A., Thornton J. E., Triboulet R., Gregory R. I., Altshuler D., Daley G. Q., The Lin28/let-7 axis regulates glucose metabolism. Cell 2011 147 1 81 94 2-s2.0-80053481600 10.1016/j.cell.2011.08.033
53. Zhang Y., Yang L., Gao Y. F., MicroRNA-106b induces mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting mitofusin-2. Molecular and Cellular Endocrinology 2013 381 1-2 230 240 10.1016/j.mce.2013.08. 004
54. Kornfeld J. W., Baitzel C., Könner A. C., Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 2013 494 7435 111 115
55. Roggli E., Britan A., Gattesco S., Lin-Marq N., Abderrahmani A., Meda P., Regazzi R., Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic β -cells. Diabetes 2010 59 4 978 986 2-s2.0-77951158889 10.2337/db09-0881
56. Melkman-Zehavi T., Oren R., Kredo-Russo S., Shapira T., Mandelbaum A. D., Rivkin N., Nir T., Lennox K. A., Behlke M. A., Dor Y., Hornstein E., miRNAs control insulin content in pancreatic β 2-cells via downregulation of transcriptional repressors. The EMBO Journal 2011 30 5 835 845 2-s2.0-79952259862 10.1038/emboj.2010.361
57. Tang X., Muniappan L., Tang G., Özcan S., Identification of glucose-regulated miRNAs from pancreatic β cells reveals a role for miR-30d in insulin transcription. RNA 2009 15 2 287 293 2-s2.0-58249107416 10.1261/rna.1211209
58. Zhao E., Keller M. P., Rabaglia M. E., Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mammalian Genome 2009 20 8 476 485 10.1007/s00335-009-9217-2
59. Nesca V., Guay C., Jacovetti C., Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 2013 56 10 2203 2212
60. Krützfeldt J., Rajewsky N., Braich R., Rajeev K. G., Tuschl T., Manoharan M., Stoffel M., Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005 438 7068 685 689 2-s2.0-28444469246 10.1038/nature04303 (Pubitemid 41740580)
61. Esau C., Davis S., Murray S. F., Yu X. X., Pandey S. K., Pear M., Watts L., Booten S. L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B. A., Freier S., Bennett C. F., Bhanot S., Monia B. P., miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism 2006 3 2 87 98 2-s2.0-33645075443 10.1016/j.cmet.2006.01.005
62. Iliopoulos D., Drosatos K., Hiyama Y., Goldberg I. J., Zannis V. I., MicroRNA-370 controls the expression of MicroRNA-122 and Cpt1 α and affects lipid metabolism. Journal of Lipid Research 2010 51 6 1513 1523 2-s2.0-77952707662 10.1194/jlr.M004812
63. Klöting N., Berthold S., Kovacs P., Schön M. R., Fasshauer M., Ruschke K., Stumvoll M., Blüher M., MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS ONE 2009 4 3 2-s2.0-62249144948 10.1371/journal.pone.0004699 e4699
64. Magenta A., Greco S., Gaetano C., Martelli F., Oxidative stress and MicroRNAs in vascular diseases. International Journal of Molecular Sciences 2013 14 9 17319 17346 10.3390/ijms140917319
65. Eades G., Yao Y., Yang M., Zhang Y., Chumsri S., Zhou Q., miR-200a regulates SIRT1 expression and Epithelial to Mesenchymal Transition (EMT)-like transformation in mammary epithelial cells. The Journal of Biological Chemistry 2011 286 29 25992 26002 2-s2.0-79960391940 10.1074/jbc.M111.229401
66. Yamakuchi M., Ferlito M., Lowenstein C. J., miR-34a repression of SIRT1 regulates apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 36 13421 13426 2-s2.0-51649115553 10.1073/pnas.0801613105
67. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., Burchfield J., Fox H., Doebele C., Ohtani K., Chavakis E., Potente M., Tjwa M., Urbich C., Zeiher A. M., Dimmeler S., MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009 324 5935 1710 1713 2-s2.0-67649998366 10.1126/science.1174381
68. Rane S., He M., Sayed D., Vashistha H., Malhotra A., Sadoshima J., Vatner D. E., Vatner S. F., Abdellatif M., Downregulation of MiR-199a derepresses hypoxia-inducible factor-1 α and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circulation Research 2009 104 7 879 886 2-s2.0-65249185780 10.1161/CIRCRESAHA.108.193102
69. Menghini R., Casagrande V., Cardellini M., Martelli E., Terrinoni A., Amati F., Vasa-Nicotera M., Ippoliti A., Novelli G., Melino G., Lauro R., Federici M., MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009 120 15 1524 1532 2-s2.0-70350134022 10.1161/CIRCULATIONAHA.109.864629
70. Devlin C., Greco S., Martelli F., Ivan M., MiR-210: more than a silent player in hypoxia. IUBMB Life 2011 63 2 94 100 2-s2.0-79952137486 10.1002/iub.427
71. Carrer M., Liu N., Grueter C. E., Williams A. H., Frisard M. I., Hulver M. W., Bassel-Duby R., Olson E. N., Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378- Proceedings of the National Academy of Sciences of the United States of America 2012 109 38 15330 15335
72. Togliatto G., Trombetta A., Dentelli P., Rosso A., Brizzi M. F., MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage. Diabetologia 2011 54 7 1930 1940 2-s2.0-79959691141 10.1007/s00125-011-2125-5
73. Onyeagucha B. C., Mercado-Pimentel M. E., Hutchison J., Flemington E. K., Nelson M. A., S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. Experimental Cell Research 2013 319 13 2081 2090 10.1016/j.yexcr.2013.05.009
74. Li L.-M., Hou D.-X., Guo Y.-L., Yang J.-W., Liu Y., Zhang C.-Y., Zen K., Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes. Journal of Immunology 2011 186 4 2552 2560 2-s2.0-79951838008 10.4049/jimmunol.1001633
75. Meerson A., Traurig M., Ossowski V., Fleming J. M., Mullins M., Baier L. J., Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF- α Diabetologia 2013 56 9 1971 1979 10.1007/s00125-013-2950-9
76. Stakos D. A., Gatsiou A., Stamatelopoulos K., Tselepis A. D., Stellos K., Platelet microRNAs: from platelet biology to possible disease biomarkers and therapeutic targets. Platelets 2013 24 8 579 589 10.3109/09537104.2012.724483
77. Hergenreider E., Heydt S., Tréguer K., Boettger T., Horrevoets A. J. G., Zeiher A. M., Scheffer M. P., Frangakis A. S., Yin X., Mayr M., Braun T., Urbich C., Boon R. A., Dimmeler S., Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nature Cell Biology 2012 14 3 249 256 2-s2.0-84857708170 10.1038/ncb2441
78. Fernandez-Hernando C., Ramírez C. M., Goedeke L., Suárez Y., MicroRNAs in metabolic disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2013 33 2 178 185 10.1161/ATVBAHA.112.300144
79. Boon R. A., Hergenreider E., Dimmeler S., Atheroprotective mechanisms of shear stress-regulated microRNAs. Thrombosis and Haemostasis 2012 108 4 616 620
80. Zampetaki A., Mayr M., MicroRNAs in vascular and metabolic disease. Circulation Research 2012 110 3 508 522 2-s2.0-84856694355 10.1161/CIRCRESAHA. 111.247445
81. Zhou J., Wang K.-C., Wu W., Subramaniam S., Shyy J. Y.-J., Chiu J.-J., Li J. Y.-S., Chien S., MicroRNA-21 targets peroxisome proliferators-activated receptor- α in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proceedings of the National Academy of Sciences of the United States of America 2011 108 25 10355 10360 2-s2.0-79959973595 10.1073/pnas.1107052108
82. Fiedler J., Jazbutyte V., Kirchmaier B. C., Gupta S. K., Lorenzen J., Hartmann D., Galuppo P., Kneitz S., Pena J. T. G., Sohn-Lee C., Loyer X., Soutschek J., Brand T., Tuschl T., Heineke J., Martin U., Schulte-Merker S., Ertl G., Engelhardt S., Bauersachs J., Thum T., MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 2011 124 6 720 730 2-s2.0-80051802344 10.1161/CIRCULATIONAHA.111.039008
83. Dignat-George F., Boulanger C. M., The many faces of endothelial microparticles. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 1 27 33 2-s2.0-78650899932 10.1161/ATVBAHA.110.218123
84. Jansen F., Yang X., Hoelscher M., Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 2013 128 18 2026 2038 10.1161/CIRCULATIONAHA.113.001720
85. Urbich C., Dimmeler S., Endothelial progenitor cells: characterization and role in vascular biology. Circulation Research 2004 95 4 343 353 2-s2.0-4143052506 10.1161/01.RES.0000137877.89448.78 (Pubitemid 39100452)
86. Wassmann S., Werner N., Czech T., Nickenig G., Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circulation Research 2006 99 8 e74 e83 2-s2.0-33749674128 10.1161/01.RES.0000246095.90247.d4 (Pubitemid 44556373)
87. Steinmetz M., Brouwers C., Nickenig G., Wassmann S., Synergistic effects of telmisartan and simvastatin on endothelial progenitor cells. Journal of Cellular and Molecular Medicine 2010 14 6B 1645 1656 2-s2.0-77955152492 10.1111/j.1582-4934.2009.00829.x
88. Meng S., Cao J., Zhang X., Fan Y., Fang L., Wang C., Lv Z., Fu D., Li Y., Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS ONE 2013 8 7 e68611
89. Hu S., Huang M., Li Z., Jia F., Ghosh Z., Lijkwan M. A., Fasanaro P., Sun N., Wang X., Martelli F., Robbins R. C., Wu J. C., MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 2010 122 11, supplement S124 S131 2-s2.0-77957243894 10.1161/CIRCULATIONAHA.109.928424
90. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., Rainaldi G., MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006 108 9 3068 3071 2-s2.0-33751173635 10.1182/blood-2006-01-012369
91. Dentelli P., Rosso A., Orso F., Olgasi C., Taverna D., Brizzi M. F., microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 8 1562 1568 2-s2.0-77955146248 10.1161/ATVBAHA.110. 206201
92. Caporali A., Meloni M., Völlenkle C., Bonci D., Sala-Newby G. B., Addis R., Spinetti G., Losa S., Masson R., Baker A. H., Agami R., Le Sage C., Condorelli G., Madeddu P., Martelli F., Emanueli C., Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after Limb Ischemia. Circulation 2011 123 3 282 291 2-s2.0-79251534433 10.1161/CIRCULATIONAHA.110.952325
93. Hulsmans M., de Keyzer D., Holvoet P., MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. The FASEB Journal 2011 25 8 2515 2527 2-s2.0-79960175448 10.1096/fj.11-181149
94. Davis B. N., Hilyard A. C., Lagna G., Hata A., SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008 454 7200 56 61 2-s2.0-46449128469 10.1038/nature07086 (Pubitemid 351931982)
95. Maegdefessel L., Azuma J., Toh R., Deng A., Merk D. R., Raiesdana A., Leeper N. J., Raaz U., Schoelmerich A. M., McConnell M. V., Dalman R. L., Spin J. M., Tsao P. S., MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Science Translational Medicine 2012 4 122 2-s2.0-84857491474 10.1126/scitranslmed.3003441 122ra22
96. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C., A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circulation Research 2009 104 4 476 486 2-s2.0-61949252089 10.1161/CIRCRESAHA.108.185363
97. Davis B. N., Hilyard A. C., Nguyen P. H., Lagna G., Hata A., Induction of MicroRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. The Journal of Biological Chemistry 2009 284 6 3728 3738 2-s2.0-63649147782 10.1074/jbc.M808788200
98. Torella D., Iaconetti C., Catalucci D., Ellison G. M., Leone A., Waring C. D., Bochicchio A., Vicinanza C., Aquila I., Curcio A., Condorelli G., Indolfi C., MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circulation Research 2011 109 8 880 893 2-s2.0-80053574272 10.1161/CIRCRESAHA.111.240150
99. Pasmant E., Laurendeau I., Héron D., Vidaud M., Vidaud D., Bièche I., Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Research 2007 67 8 3963 3969 2-s2.0-34248547495 10.1158/0008-5472.CAN-06-2004 (Pubitemid 46762186)
100. Pasmant E., Sabbagh A., Vidaud M., Bièche I., ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. The FASEB Journal 2011 25 2 444 448 2-s2.0-79551623370 10.1096/fj.10-172452
101. Wahlestedt C., Targeting long non-coding RNA to therapeutically upregulate gene expression. Nature Reviews Drug Discovery 2013 12 6 433 446
102. Sharpless N. E., DePinho R. A., How stem cells age and why this makes us grow old. Nature Reviews Molecular Cell Biology 2007 8 9 703 713 2-s2.0-34548153747 10.1038/nrm2241 (Pubitemid 47312828)
103. Holdt L. M., Hoffmann S., Sass K., Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genetics 2013 9 7 10.1371/journal.pgen.1003588 e1003588
104. Morán I., Akerman I., van de Bunt M., Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metabolism 2012 16 4 435 448 10.1016/j.cmet.2012.08.010